Stanford inventors have developed a novel diagnostic tool that identifies distinct immune signatures in the peripheral blood of osteoarthritis patients using mass cytometry (CyTOF) and applied machine learning.
Researchers at Stanford University have formulated a novel biomaterial suitable for three-dimensional (3D) bioprinting: a homogeneous composite of polycaprolactone (PCL), gelatin, and beta-tricalcium phosphate.
Researchers at Stanford have developed a porous biologics-loaded multimaterial construct, called Hybrid Tissue Engineering Construct (HyTEC), with applications in regenerative medicine and therapeutic delivery.
Based on their proprietary HyTEC tissue engineering platform, researchers at Stanford have developed an osteoinductive intramedullary implant (IM) device for improved bone healing.
Researchers at Stanford have developed a biodegradable device and platform carrier of biologics for promoting faster bone healing of large bone defects, fractures, and non-union.
Researchers at Stanford have developed a biodegradable device and platform carrier of biologics for promoting faster bone healing of large bone defects, fractures, and non-union.
Knee osteoarthritis is the most common cause of musculoskeletal pain in adults, leading to limited mobility and various health issues. This breakthrough technology developed by Stanford researchers offers a promising solution.
A Stanford inventor has developed a soft grommet/eyelet to load share and prevent suture pull-through of the repair stitch and a device to pass the eyelet.
For orbital fractures, there are advanced solutions for the restoration of bony contour following trauma but the most debilitating functional consequences (pain and double vision) are due to soft tissue injury and entrapment rather than bony distortion.
A Stanford bioengineering researcher developed an optical sensor based muscle and body motion tracking system for use with prosthetics and wearable human machine interfaces.
Stanford researchers have designed hydrogels that can be delivered to surgical sites in a patient's body for controlled and sustained release of bacteriophages to treat or prevent bacterial infections.
Stanford inventors have developed a functionally-graded implant device for the reconstitution of the necrotic area removed after surgical treatment of osteonecrosis of the hip.
Stanford researchers have developed a technique to interpret contact events between a human and a device equipped with a force sensor. It can detect and classify distinct touch interactions such as tap, touch, grab, and slip.